Leitat Technological Center together with industry partner ReadyCell S.L. and public research institution Vall d’Hebron Institute of Research (VHIR) – Vall d’Hebron Institut de Recerca recently celebrated the 1-Year Consortium Meeting for their collaborative project MPS-LOC: Microphysiological systems based on liver on chip for drug discovery and testing.
The main objective of this project is to develop Liver-on-chip systems converging microfluidics, 3D printing, human-derived liver cells and liver derived bioinks to substitute the use of animal models for drug discovery. Liver-on-chips will have high predictive value for in drug development in preclinical settings.
The project consortium involves leading partners in different expertise areas to ensure the success of this innovative proposal. Members of the Donation and Transplant Coordination Department as well as both the Paediatric Hepatic Transplants Unit and the Hepatobiliary and Pancreatic Surgery and Transplants Department from Vall d’Hebron University Hospital, and their respective research groups (Donation and transplantation of organs, tissues and cells and HBP and Liver Transplantation) from Vall d’Hebron Institut de Recerca (VHIR), the Leitat’s Medical Department and Diagnostic Devices research group from Leitat Technological Center and Industry partner ReadyCell, have shared recent advances in their work in MPS-LOC.
We thank all the consortium partners for the great discussion contributing to a very fruitful meeting.
The MPS-LOC project coordinated by Leitat was awarded the competitive grant “Proyectos de I+D+i en Líneas Estratégicas 2022” from the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovación) through its funding agency Agencia Estatal de Investigación (AEI).